News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Greifensee, 01st March, 2018 – It started with a fluffy mass of mold that required a microscope to reveal its groundbreaking potential. This is how penicillin – the world’s first antibiotic was discovered. Today researchers deal with a wide range of costly ingredients that require testing in small sample sizes to make the production process... Read more
LAS VEGAS, March 5, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help close the communication gaps across the medication management process through increased interoperability, enhanced cybersecurity and expanded partnerships at the 2018 HIMSS Annual Conference being... Read more
Download PDF SAN FRANCISCO, Calif. and CARLSBAD, Calif. – February 28, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its North American operations with a new office in the San Diego area. The office will support sales and marketing as... Read more
MACON, GA – February 22, 2018 — GE Healthcare and Navicent Health have announced plans to transform healthcare delivery and reduce the cost of care in central Georgia for the benefit of the local community. Over the course of the next six years, the two entities will work side by side to make system-wide improvements... Read more
Download PDF SAN FRANCISCO, Calif. – February 14, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit,... Read more
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number... Read more
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced its Single Molecule, Real-Time (SMRT®) Sequencing technology will be demonstrated in several presentations and posters at the annual Advances in Genome Biology & Technology (AGBT) conference taking place February 12-15 in Orlando. PacBio is also an official sponsor of this... Read more
–Joining forces for single-cell research excellence– PLEASANTON, CA.—February 21, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in... Read more
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation into whether Oxford Nanopore’s MinION and PromethION devices and associated consumables, reagents, and software infringe one or more claims of U.S. Patent Nos. 9,404,146 and 9,542,527, owned... Read more
San Carlos, California , Feb 08, 2018 Today NuGEN Technologies announces a breakthrough DNA-Seq library system giving researchers a simplified library preparation system for Illumina sequencers. The new system, Celero™ DNA-Seq, features a fast, addition-only workflow that eliminates in-process bead purifications. The system also features a breakthrough library quantitation method that saves both time and cost. In line with... Read more